PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
February 12, 20260 citations

LYSC98 as a novel vancomycin-derived agent effective against antibiotic-resistant pathogens in tolerant state.

View Full Paper
XXXing XiaMGMei GeJCJie Chen

Key Points

  • The research aims to evaluate the effectiveness of LYSC98 in treating antibiotic-resistant infections.
  • Assessed the bactericidal activity of LYSC98 against resistant pathogens
  • Evaluated the selective disruption of bacterial cells versus mammalian cells
  • Investigated the development of resistance to LYSC98.
  • LYSC98 shows rapid bactericidal activity against resistant bacteria
  • Disruption of bacterial cells occurs without damaging mammalian cells
  • Low risk of resistance development observed in test conditions.

Abstract

LYSC98's rapid bactericidal activity, selective disruption of bacteria without harming mammalian cells and low propensity for resistance development make it a novel promising candidate for combating chronic, clinically recalcitrant infections.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Xia et al. (2026) studied this question.

synapsesocial.com/papers/698d6e925be6419ac0d54665https://doi.org/10.1093/jac/dkag036
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Increasing relevance of Gram-positive cocci in urinary tract infections: a 10-year analysis of their prevalence and resistance trends2020 · 108 citations
  2. 2Hydrophobic modification improves the delivery of cell-penetrating peptides to eliminate intracellular pathogens in animals2022 · 59 citations
  3. 3Intracellular activity of a membrane-active glycopeptide antibiotic against meticillin-resistant Staphylococcus aureus infection2016 · 18 citations
  4. 4Biological barriers, and the influence of protein binding on the passage of drugs across them2020 · 181 citations
  5. 5Pharmacokinetics and Pharmacodynamics of a Novel Vancomycin Derivative LYSC98 in a Murine Thigh Infection Model Against Staphylococcus aureus2023 · 10 citations